Desloratadine as the selective 5HT2AR antagonist suppresses neutrophil extracellular traps formation to ameliorate diabetic peripheral neuropathy pathology. - Lu, Dayun; Ruan, Yuan; Zhou, Fan; Ma, Yan; Chang, Jieru; Wei, Yuxi; Xu, Rui; Wang, Jiaying; Shen, Xu (Journal of Neuroinflammation, 2025)